IGM Biosciences IGMS

$ 8.78 -10.11%

Quarterly report 2024-Q3
added 11-08-2024

IGM Biosciences Balance Sheet 2011-2024 | IGMS

Annual Balance Sheet IGM Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-72 M	-80.1 M	-105 M	-	-21.2 M	3.14 M	-432 K	-	-	-	-	-	-
Long Term Debt	34.7 M	35.4 M	25.4 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	5.83 M	5.82 M	3.32 M	2.67 M	2.48 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	12.2 M	60.9 M	40.9 M	-	-	-	-	-	-
Total Current Liabilities	42.5 M	44.7 M	27.8 M	17.2 M	8.88 M	-	-	-	-	-	-	-	-
Total Liabilities	220 M	226 M	53.2 M	26.8 M	21.1 M	69.8 M	41.9 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-821 M	-575 M	-354 M	-189 M	-107 M	-64.1 M	-41.4 M	-	-	-	-	-	-
Total Assets	423 M	513 M	298 M	409 M	261 M	3.98 M	1.39 M	-	-	-	-	-	-
Cash and Cash Equivalents	113 M	121 M	133 M	241 M	35.9 M	1.89 M	-	-	-	-	-	-	-
Book Value	203 M	287 M	245 M	382 M	240 M	-65.8 M	-40.5 M	-	-	-	-	-	-
Total Shareholders Equity	203 M	287 M	245 M	382 M	240 M	-65.8 M	-40.5 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet IGM Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	39.2 M	33.4 M	34.3 M	35 M	34.5 M	34.9 M	35.4 M	23.7 M	24.9 M	25.9 M	25.4 M	26.2 M	9.15 M	10 M	9.58 M	9.58 M	9.58 M	9.58 M	12.2 M	12.2 M	12.2 M	12.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	226 M	214 M	215 M	220 M	222 M	223 M	226 M	213 M	207 M	53.2 M	53.2 M	46.7 M	28.2 M	24.9 M	26.8 M	26.8 M	26.8 M	26.8 M	21.1 M	21.1 M	21.1 M	21.1 M	8.89 M	8.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-980 M	-919 M	-871 M	-761 M	-699 M	-634 M	-575 M	-522 M	-464 M	-406 M	-354 M	-303 M	-259 M	-220 M	-189 M	-189 M	-189 M	-189 M	-107 M	-107 M	-107 M	-107 M	-64.1 M	-64.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	305 M	337 M	376 M	474 M	481 M	463 M	513 M	541 M	582 M	258 M	298 M	332 M	351 M	380 M	409 M	409 M	409 M	409 M	261 M	261 M	261 M	261 M	3.98 M	3.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	42.9 M	67 M	79.2 M	175 M	151 M	140 M	121 M	177 M	221 M	75.4 M	133 M	166 M	246 M	252 M	241 M	241 M	241 M	241 M	35.9 M	35.9 M	35.9 M	35.9 M	1.89 M	1.89 M	-	-	432 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	78.9 M	122 M	161 M	254 M	259 M	239 M	287 M	328 M	375 M	205 M	245 M	286 M	322 M	356 M	382 M	382 M	382 M	382 M	240 M	240 M	240 M	240 M	-4.91 M	-4.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	78.9 M	122 M	161 M	254 M	259 M	239 M	287 M	328 M	375 M	205 M	245 M	286 M	322 M	356 M	382 M	382 M	382 M	382 M	240 M	240 M	240 M	240 M	-65.8 M	-65.8 M	-43.7 M	-43.4 M	-40.5 M	-	-	-	-29.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency